Julie D Klapstein - Net Worth and Insider Trading

Julie D Klapstein Net Worth

The estimated net worth of Julie D Klapstein is at least $751,003 dollars as of 2024-04-27. Julie D Klapstein is the Director of Amedisys Inc and owns about 7,993 shares of Amedisys Inc (AMED) stock worth over $733,677. Julie D Klapstein is also the Director of MultiPlan Corp and owns about 30,105 shares of MultiPlan Corp (MPLN) stock worth over $17,325. Details can be seen in Julie D Klapstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Julie D Klapstein has not made any transactions after 2021-08-20 and currently still holds the listed stock(s).

Transaction Summary of Julie D Klapstein

To

Julie D Klapstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Julie D Klapstein owns 5 companies in total, including NextGen Healthcare Inc (NXGN) , Oak Street Health Inc (OSH) , and Amedisys Inc (AMED) among others .

Click here to see the complete history of Julie D Klapstein’s form 4 insider trades.

Insider Ownership Summary of Julie D Klapstein

Ticker Comapny Transaction Date Type of Owner
NXGN NextGen Healthcare Inc 2017-08-22 director
OSH Oak Street Health Inc 2020-08-05 director
AMED Amedisys Inc 2021-06-08 director
SRCTQ Standard Register Co 2013-10-31 director
MPLN MultiPlan Corp 2021-08-20 director

Julie D Klapstein Latest Holdings Summary

Julie D Klapstein currently owns a total of 2 stocks. Among these stocks, Julie D Klapstein owns 7,993 shares of Amedisys Inc (AMED) as of April 1, 2020, with a value of $733,677 and a weighting of 97.69%. Julie D Klapstein also owns 30,105 shares of MultiPlan Corp (MPLN) as of August 20, 2021, with a value of $17,325 and a weighting of 2.31%.

Latest Holdings of Julie D Klapstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMED Amedisys Inc 2020-04-01 7,993 91.79 733,677
MPLN MultiPlan Corp 2021-08-20 30,105 0.58 17,325

Holding Weightings of Julie D Klapstein


Julie D Klapstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Julie D Klapstein has made a total of 2 transactions in Amedisys Inc (AMED) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Amedisys Inc is the sale of 250 shares on April 1, 2020, which brought Julie D Klapstein around $44,660.

According to the SEC Form 4 filings, Julie D Klapstein has made a total of 1 transactions in MultiPlan Corp (MPLN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in MultiPlan Corp is the acquisition of 12,000 shares on August 20, 2021, which cost Julie D Klapstein around $72,000.

Insider Trading History of Julie D Klapstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Julie D Klapstein Trading Performance

GuruFocus tracks the stock performance after each of Julie D Klapstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Julie D Klapstein is -41.04%. GuruFocus also compares Julie D Klapstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Julie D Klapstein within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Julie D Klapstein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Julie D Klapstein

Average Return

-36.52%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.52 -41.04 -28.31 -36.52 -48.49
Relative Return to S&P 500(%) -1.63 -46.81 -26.22 -31.72 -47.67

Julie D Klapstein Ownership Network

Ownership Network List of Julie D Klapstein

No Data

Ownership Network Relation of Julie D Klapstein


Julie D Klapstein Owned Company Details

What does NextGen Healthcare Inc do?

Who are the key executives at NextGen Healthcare Inc?

Julie D Klapstein is the director of NextGen Healthcare Inc. Other key executives at NextGen Healthcare Inc include 10 percent owner Three Prong Investments, Llc , Chief Technology Officer David A Metcalfe , and EVP & Commercial Growth Mitchell Waters .

NextGen Healthcare Inc (NXGN) Insider Trades Summary

Over the past 18 months, Julie D Klapstein made no insider transaction in NextGen Healthcare Inc (NXGN). Other recent insider transactions involving NextGen Healthcare Inc (NXGN) include a net sale of 64,744 shares made by David A Metcalfe , and a net sale of 9,783 shares made by Mitchell Waters .

In summary, during the past 3 months, insiders sold 0 shares of NextGen Healthcare Inc (NXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 74,527 shares of NextGen Healthcare Inc (NXGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,527 shares.

NextGen Healthcare Inc (NXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NextGen Healthcare Inc Insider Transactions

No Available Data

Julie D Klapstein Mailing Address

Above is the net worth, insider trading, and ownership report for Julie D Klapstein. You might contact Julie D Klapstein via mailing address: 1239 Fruit Cove Road North, Jacksonville Fl 32259.

Discussions on Julie D Klapstein

No discussions yet.